INBS — Intelligent Bio Solutions Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Intelligent Bio Solutions, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-3.19	-7.06	-8.33	-10.7	-10.2
Depreciation
Non-Cash Items	0.067	0.704	2.54	2.39	0.347
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	2.63	-4.94	2.44	0.079	-0.702
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-0.499	-11.3	-3.36	-7.38	-9.57
Capital Expenditures	—	—	—	—	-0.005
Purchase of Fixed Assets
Other Investing Cash Flow Items	-0.014	—	-0.88	-0.694	-0.216
Acquisition of Business
Sale of Business
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities	-0.014	—	-0.88	-0.694	-0.221
Financing Cash Flow Items	-0.116	-2	0	-1.33	9.12
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.734	23.4	0	1.44	14.6
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.229	12.1	-4.34	-6.7	4.77